1. "Sean Devlin"
  2. "Nikoletta Lendvai"
Formats
  1. Meeting Abstract (31)
  2. Journal Article (15)
  3. Research Letter (1)
Groups
  1. Biostatistics Service (47)
  2. Center for Hematologic Malignancies (47)
  3. Department of Medicine (47)
  4. Epidemiology and Biostatistics (47)
  5. Hematologic Malignancies Research (47)
  6. Hematologic Malignancies, Division of (47)

More Groups

People
  1. Nikoletta Lendvai (47)
  2. Sean Devlin (47)
  3. Sergio Giralt (45)
  4. Alexander Lesokhin (44)
  5. David Chung (44)
  6. Hani Hassoun (44)

More People

Years
  1. 2022 (1)
  2. 2021 (1)
  3. 2020 (3)
  4. 2019 (1)
  5. 2018 (5)
  6. 2017 (11)

More Years

Publications
  1. Blood (20)
  2. Biology of Blood and Marrow Transplantation (10)
  3. Leukemia and Lymphoma (6)
  4. Bone Marrow Transplantation (4)
  5. Clinical Lymphoma, Myeloma and Leukemia (3)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Hematology (20)
  2. Elsevier Inc. (13)
  3. Taylor & Francis Group (6)
  4. Nature Publishing Group (5)
  5. American Society of Clinical Oncology (1)
  6. Ferrata Storti Foundation (1)

More Publishers

Results (47)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Continuous induction with lenalidomide/dexamethasone versus autologous stem cell transplantation in newly diagnosed multiple myeloma: A case for response-adapted approach
    Journal Article

    Lahoud, O. B.; Landau, H.; Nguyen, J.; Devlin, S.; Lendvai, N.; Weltz, J.; Ayorinde, T.; Chung, D. J.; Lesokhin, A. M.; Kewalramani, T.; more...
    Leukemia and Lymphoma (2022)

    Fulltext@MSK | Save
  • Tailored treatment to MRD response: A phase I/II study for newly diagnosed multiple myeloma patients using high dose twice-weekly carfilzomib (45 and 56 mg/m2) in combination with lenalidomide and dexamethasone
    Research Letter

    Korde, N.; Mastey, D.; Tavitian, E.; Mailankody, S.; Lesokhin, A.; Hassoun, H.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Shah, U.; more...
    American Journal of Hematology (2021)

    Fulltext@MSK | Save
  • Association of patient activity bioprofiles with Hrqol and clinical responses: A prospective novel trial using mobile wearables in newly diagnosed multiple myeloma patients
    Meeting Abstract

    Korde, N.; Tavitian, E.; Derkach, A.; Zarski, A.; Salcedo, M.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Lendvai, N.; Smith, E. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Stem cell mobilization and autograft minimal residual disease negativity with novel induction regimens in multiple myeloma
    Journal Article

    Bal, S.; Landau, H. J.; Shah, G. L.; Scordo, M.; Dahi, P.; Lahoud, O. B.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Lendvai, N.; more...
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Pilot study of bortezomib and dexamethasone pre- and post-risk-adapted autologous stem cell transplantation in AL amyloidosis
    Journal Article

    Landau, H.; Lahoud, O.; Devlin, S.; Lendvai, N.; Chung, D. J.; Dogan, A.; Landgren, C. O.; Giralt, S.; Hassoun, H.
    Biology of Blood and Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Ixazomib and dexamethasone in high risk smoldering multiple myeloma: A clinical and correlative pilot study
    Meeting Abstract

    Mailankody, S.; Salcedo, M.; Tavitian, E.; Korde, N.; Lendvai, N.; Hassoun, H.; Lesokhin, A. M.; Lahoud, O. B.; Smith, E. L.; Hultcrantz, M.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • MRD-response driven phase I/II study for newly diagnosed multiple myeloma patients using higher doses of twice-weekly carfilzomib (45 and 56 mg/m(2)) in combination with lenalidomide and dexamethasone
    Meeting Abstract

    Korde, N.; Mastey, D.; Mailankody, S.; Hassoun, H.; Lesokhin, A. M.; Smith, E. L.; Lendvai, N.; Hultcrantz, M.; Tavitian, E.; Salcedo, M.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Depth of response and outcomes in patients with multiple myeloma undergoing autologous stem cell transplantation
    Meeting Abstract

    Shah, G. L.; Seier, K.; Devlin, S. M.; Chung, D. J.; Scordo, M.; Hultcrantz, M.; Korde, N.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Treatment outcomes in monoclonal immunoglobulin deposition disease (MIDD): A two center experience
    Meeting Abstract

    Pianko, M. J.; Tiutan, T.; Flynn, J.; Devlin, S. M.; Jaffer-Sathick, I.; Rossi, A. C.; Salvatore, S. P.; Landau, H. J.; Lendvai, N.; Smith, E. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Predictive biomarkers and practical considerations in the management of carfilzomib-associated cardiotoxicity
    Journal Article

    Lendvai, N.; Tsakos, I.; Devlin, S. M.; Schaffer, W. L.; Hassoun, H.; Lesokhin, A. M.; Landau, H.; Korde, N.; Mailankody, S.; Smith, E.; more...
    Leukemia and Lymphoma (2018)

    Fulltext@MSK | Save